IMPACT May 2020
Launching a clinical trial in the midst of a pandemic
In early March 2020, as it became clear the novel coronavirus was closing in on Southern California, clinical trials leaders from the Department of Research & Evaluation began assessing options for an investigational treatment that could be studied through clinical trials. And so began one of the largest clinical trials in Kaiser Permanente history.
R&E News and Features
Video: Clinical trials
In this video, the first of a series, William J. Towner, MD, FACP, FIDSA, regional physician director for clinical trials at Kaiser Permanente Southern California, describes how clinical trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more.
Stroke program integrates clinical trials
At Kaiser Permanente Southern California, physicians and researchers have been transforming stroke care, from simply treating patients to also enrolling those not helped by the standard care into a clinical trials program, expanding their treatment options.
English and non-English speakers get equal treatment in emergency departments
Kaiser Permanente Southern California researchers set out to understand the importance of emergency department patients and physicians speaking the same language by looking at the health outcomes and quality of care for patients with chest pain. They hypothesized that patients speaking a different language than their physician may have worse outcomes. They were happy to find their hypothesis was wrong.
Declines in heart attacks greater among men than women
In a recently published study, Kaiser Permanente research scientists found a steady decline in heart attacks for both men and women enrolled in the health system from 2000 to 2014, although that rate of decline slowed among women in the last 5 years of the study.
In the News
When COVID-19 crosses paths with HIVHutch NewsMay 8, 2020
Kaiser Permanente research centers prioritize urgent COVID-19 research projects, clinical trialsPermanente MedicineMay 2, 2020
COVID-19 grant award for urgently needed cardiovascular researchDepartment of Research & Evaluation NewsMay 1, 2020
Tierresanta COVID-19 survivor participated in remdesivir trialNBC San DiegoApril 29, 2020
‘Disease detective’ alumna works at the front lines of COVID-19Willamette UniversityApril 23, 2020
MI incidence declining more slowly in womenHealioFebruary 28, 2020
Sugary coffee drinks tied to poor sleep for young womenReutersFebruary 4, 2020
for Dr. Deborah Cohen
Deborah A. Cohen, MD, MPH, an international expert on the health benefits of parks, is the newest scientist at the Department of Research & Evaluation. She began working in the department’s Division of Behavioral Research in January.